Galderma Laboratories L.Pal Revenue and Competitors
Estimated Revenue & Valuation
- Galderma Laboratories L.Pal's estimated annual revenue is currently $62.5M per year. 0
Galderma Laboratories L.Pal Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Galderma Laboratories L.Pal?
CollaGenex Pharmaceuticals, Inc. is a specialty pharmaceutical company currently focused on providing innovative medical therapies to the dental and dermatology markets. The Company's lead product, Periostat, was approved by the FDA in September 1998 and is the first and only pharmaceutical to treat periodontal disease by inhibiting the enzymes that destroy periodontal support tissues.keywords:N/A
Number of Employees
Employee Growth %
Galderma Laboratories L.Pal News
For instance, in 2021, Galderma Laboratories, L.P.-Cetaphil ... L.P., PDI, Inc., Betco Corporation, Pal International, PSK Pharma Pvt. Ltd.,...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|